Bioxytran Statistics

Total Valuation

Bioxytran has a market cap or net worth of 12.00 million. The enterprise value is 13.30 million.

Market Cap	12.00M
Enterprise Value	13.30M

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Bioxytran has 88.88 million shares outstanding. The number of shares has decreased by -16.68% in one year.

Current Share Class	88.88M
Shares Outstanding	88.88M
Shares Change (YoY)	-16.68%
Shares Change (QoQ)	-4.40%
Owned by Insiders (%)	0.56%
Owned by Institutions (%)	n/a
Float	88.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-4.43
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.21
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.00

Current Ratio	0.00
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.54

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-939.80%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	72.63%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.74% in the last 52 weeks. The beta is 1.85, so Bioxytran's price volatility has been higher than the market average.

Beta (5Y)	1.85
52-Week Price Change	+7.74%
50-Day Moving Average	0.15
200-Day Moving Average	0.11
Relative Strength Index (RSI)	47.61
Average Volume (20 Days)	113,463

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.97M
Pretax Income	-3.16M
Net Income	-3.16M
EBITDA	-1.96M
EBIT	-1.97M
Earnings Per Share (EPS)	-0.03

Full Income Statement

Balance Sheet

The company has 4,348 in cash and 1.26 million in debt, giving a net cash position of -1.26 million or -0.01 per share.

Cash & Cash Equivalents	4,348
Total Debt	1.26M
Net Cash	-1.26M
Net Cash Per Share	-0.01
Equity (Book Value)	-2.71M
Book Value Per Share	-0.03
Working Capital	-2.84M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-113,493
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioxytran does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	16.68%
Shareholder Yield	n/a
Earnings Yield	-26.33%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a